Send us a text

Join us as we return with another special episode with Professor Alison Birtle.

This time we discuss Upper Tract Urothelial (or ureteric) Cancer.

Alison is an internationally recognised expert in this area and was lead on the POUT adjuvant chemotherapy in ureteric cancer trial.

She describes it as the non-identical twin to bladder urothelial cancer and we discuss the different approaches to this rare cancer.

Described as 'The Queen of Upper Tract Urothelial Cancer' she shares her views on management and areas for development.

Enjoy

Send us a text

🚨May is Bladder Cancer Awareness Month

🎙️What better way to mark this than a Simply Oncology Podcast - Bladder Cancer episode with the irrepressible Professor Alison Birtle. Alison is an internationally recognised expert in bladder and prostate cancer - and is a Simply Oncology Friend of the Show.

🎙️We discuss the recent peri-operative trials such as NIAGARA
🎙️What do surgical adjuvant and neoadjuvant trails now mean for the bladder cancer pathway?

Send us a text

🤔Do you know your Cancer of Unknown Primary from your Malignancy of Unknown Origin.

🤔Do you think World CUP Alliance is a football tournament?

Cancer of unknown primary is the 6th most common cause of cancer death in the UK

🎙️Find out with Dr Natalie Cook from The Christie Hospital who is a UK expert in CUP.

Send us a text

Part 2 of our discussion on bladder cancer with Professor Rob Jones.

We have new drug classes in Bladder cancer !!

We look at Erdafitinib which is coming in the post Immunotherapy space to NHS England.

We also look ahead to Antibody Drug Conjugates - in particular Enfortumab Vedotin - with EV 302 trial results and what access to this means for the UK bladder community.

These are exciting times and we discuss potential side effects of these classes of drugs and how we intend to use them.

Enjoy

Send us a text

The Royal College of Radiologists celebrates 50 years of Royal Charter this year!!!

Join us as we explore 50 years of the RCR Royal Charter with the President - Dr Katharine Halliday and Vice President - Dr Tom Roques.

We look at the achievements of the Royal College of Radiologists have made over the years and look to the future of cancer care at the RCR.

We hear how the RCR is our voice as a community of Radiologists and Oncologists.

It guides our learning and sets the standards for our training and profession.

We even justify the membership fees for any sceptics.

In this our 50th episode of the Simply Oncology Podcast we celebrate the Royal College of Radiologists 50th anniversary of Royal Charter Status!!

Send us a text

Join us for this Simply Oncology is Back in Bladder Cancer with the amazing Prof Rob Jones.

Part 1 of 2 on a free ranging overview of metastatic bladder cancer treatment in the UK.

Cisplatin vs Carboplatin

Role of IO

2nd line chemo?

Send us a text

Join us for this episode where we explore Head and Neck cancers and their treatment.

This is a group of cancers from the mouth to the vocal cords and make up the 8th most common group of cancers in the UK.

Almost 13000 cases happen each year in the UK.

We discuss the major role that radiotherapy plays and the process and side effects.

Teamwork is a major component of Head and Neck cancer therapy.

We also discuss how immunotherapy has a role in advanced Head & Neck cancer.

A must listen for anyone supporting or being treated for Head & Neck cancer.

Send us a text

Welcome back for our 2nd part of our radiotherapy update on breast cancer.

We finish our discussion with Professor Mark Beresford who is Chair of the UK Breast Group.

We discuss the timing of radiotherapy around breast reconstruction.

We look at situations where we treat other areas such and above the collar bone (supraclavicular) or central area (internal mammary) areas.

We examine when radiotherapy may be offered after mastectomy.

We also look at when we may be able to avoid using radiotherapy after breast surgery in low risk cases.

Another must listen.